ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2025
Beyond Cardiometabolic: Health Disorders Risk in Metabolically Healthy Obese Children - A Systematic Review and Meta-Analysis of 19,119 Children.
Review in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objectives: Childhood obesity is associated with both short-term and long-term health complications, yet a new obesity phenotype called metabolically healthy obesity (MHO) has emerged. While MHO is often perceived as a "benign" form of obesity, research specifically examining health disorders risks in children with MHO remains limited. This systematic review and meta-analysis aimed to evaluate health disorders in children with MHO. Methods: Following PRISMA 2020 guidelines, we systematically searched five databases (PubMed, Scopus, Google Scholar, EBSCO, and ScienceDirect) for observational studies examining MHO children aged 0-18 years. The studies were analyzed using R and R Studio software, with study quality assessed using the Newcastle Ottawa Scale. Results: Ten studies with a total of 19,119 children were included in this review. Children with MHO demonstrated significantly higher overall health disorders risk compared to MHNW children (pooled OR 2.88, 95% CI [1.64; 5.06]). This trend aligns with the subgroups analysis of left ventricle hypertrophy, hypertension, and kidney damage. However, some of the subgroup analyses showed insignificant results. Additionally, MHO children showed lower risks of experiencing health disorders compared to MUO children (pooled OR 0.56, 95% CI [0.23; 1.34]). The underlying mechanism of the increased health risk is excess adipokines causing systemic inflammation and leading to increased various health risks. Conclusion: Despite metabolically "healthy" status, children with MHO remain at increased risk for health disorders compared to normal-weight peers. This systematic review and meta-analysis is the first one discussing the health disorders in children with MHO. More studies are required in the future to reinforce these findings in order to produce much more comprehensive insights.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.